(Q33394967)

26 July 2017

title

Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients (English)

1 reference

26 July 2017

1 reference

Peter Schlenke

1

1 reference

26 July 2017

Wibke Hagenah

2

1 reference

26 July 2017

Johannes Irsch

3

1 reference

26 July 2017

David Sundin

4

1 reference

26 July 2017

Laurence Corash

5

1 reference

26 July 2017

Lily Lin

6

1 reference

26 July 2017

Holger Kirchner

7

1 reference

26 July 2017

Thomas Wagner

8

1 reference

26 July 2017

publication date

19 April 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

90

1 reference

26 July 2017

issue

12

1 reference

26 July 2017

page(s)

1457-1465

1 reference

Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Emerging infectious threats to the blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Factors influencing 20-hour increments after platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1222-3

10.1007/S00277-011-1222-3

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference